We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Ombudsman Wants EMA to Address Clinical Trial Data Redaction
Ombudsman Wants EMA to Address Clinical Trial Data Redaction
December 16, 2014
The European Medicines Agency says it wasn’t violating any laws when it allowed AbbVie to redact information from clinical study reports, the latest twist in the debate over trial data transparency.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor